Logo
BD Flu+ Syringes 23G 0.25–1 mL 25 mm (1\) Orange – Box of 200

BD Flu+ Syringes 23G 0.25–1 mL 25 mm (1\) Orange – Box of 200

Becton Dickinson

Medical device – syringe with fixed needle
  • CE Marked medical device under the applicable European medical device legislation for hypodermic syringes with fixed needles.
  • Manufactured under an ISO 13485 Certified quality management system for medical devices.
  • Designed to meet or exceed ISO standards for sterile hypodermic syringes and needles (e.g., ISO 7886 1 for syringes for manual use and ISO 7864 for hypodermic needles), including requirements for leak tightness and graduation accuracy.
  • Sterilisation validated according to relevant EN ISO standards for ethylene oxide or equivalent sterilisation of healthcare products, with an appropriate sterility assurance level.
  • Biocompatibility of materials assessed in accordance with ISO 10993 series standards for medical devices with blood and tissue contact.
  • Packaging and sterile barrier systems validated per EN ISO 11607 for terminally sterilised medical devices.
  • Labelled as not made with natural rubber latex, in line with regulatory and industry guidance to minimise latex Related allergic reactions.
  • Listed in various national and institutional vaccine programme documentation as a low Dead Space combined needle and syringe for vaccine administration.
Low-dead-space vaccine syringe, 0.25\u20131 mL, 23G x 25 mm, fixed needle

Description

BD Flu+ syringes 23G 0.25–1 mL 25 mm (1\) Orange – Box of 200 are sterile, single-use, low-dead-space vaccine syringes with a pre-attached 25-gauge, 25 mm (1 inch) hypodermic needle. The BD Flu+ syringe is a two-piece syringe (barrel and plunger) with an integral fixed needle, designed specifically for vaccine administration and general-purpose aspiration and injection of fluids from vials and ampoules. It offers a variable dose up to 1 mL with a clear barrel and scale markings from 0.25 mL to 1 mL in 0.25 mL increments, supporting multi-dose vial use. A dose-sparing, low-dead-space plunger minimises vaccine waste, while the ISO colour-coded orange plunger rod allows quick identification of the 23G needle gauge. The device is not made with natural rubber latex and is supplied in boxes of 200 individually sterile syringes.

Bnefits

  • Low-dead-space design with dose-sparing plunger helps minimise residual vaccine volume and reduces medication waste.
  • Variable-dose syringe with clear barrel and 0.25–1 mL scale markings in 0.25 mL increments supports accurate dosing from multi-dose vials.
  • Pre-attached, fixed 23G x 25 mm (1") needle simplifies set-up, reduces the number of components to manage and helps ensure the correct needle is used for standard vaccine administration.
  • ISO colour-coded orange plunger rod facilitates quick visual identification of the 23G needle gauge at point of use.
  • Two-piece syringe construction (barrel and plunger) with lubricant in the barrel provides smooth plunger movement without a separate rubber stopper.
  • Low dead space (typically < 35 microlitres) between syringe and fixed needle hub supports maximum dose extraction from multi-dose vials.
  • Clear, transparent barrel allows easy visual inspection of vaccine solution, air bubbles and volume during preparation and injection.
  • Sterile, single-use device designed to reduce cross-contamination risk and support infection prevention in vaccination programmes.
  • Not made with natural rubber latex, helping to reduce the risk of latex-associated allergic reactions in patients and healthcare workers.
  • Developed for high-volume immunisation settings, supporting streamlined workflow and standardisation across seasonal flu and other vaccine campaigns.

Indications

  • Aspiration and injection of vaccines and other medicinal fluids from vials and ampoules up to a maximum dose of 1 mL.
  • General-purpose intramuscular, subcutaneous and intradermal injection of approved medicinal products when a 23G x 25 mm (1") fixed needle and 1 mL syringe are clinically appropriate.
  • Use in mass vaccination programmes (e.g., influenza, COVID-19 and other routine immunisations) where low-dead-space, dose-sparing syringes are recommended to optimise vaccine utilisation.
  • Use in hospital, primary care, occupational health, community clinics and pharmacy-based vaccination services by trained healthcare professionals.
  • Use in adult and adolescent patients (and older children where clinically appropriate) requiring standard-depth intramuscular or subcutaneous injections with a 23G 25 mm needle.

Composition

  • Barrel: Medical-grade transparent polypropylene (PP).
  • Plunger rod: Medical-grade polypropylene (PP), ISO colour-coded orange for 23G identification.
  • Plunger tip (integral to plunger in two-piece design): Polypropylene with internal lubrication effect from barrel, no separate rubber stopper.
  • Needle cannula: Stainless steel hypodermic tubing, 23G (0.5 mm diameter), 25 mm (1 inch) length, regular bevel.
  • Needle hub: Medical-grade plastic (e.g., polypropylene or equivalent) permanently bonded to the syringe barrel (fixed, non-removable needle).
  • Lubricant: Medical-grade silicone oil or similar applied to the barrel interior to reduce sliding friction between barrel and plunger.
  • Printing: Medical-grade ink for barrel graduation markings.
  • Latex status: Natural rubber latex is not part of the material formulation.
  • Plasticiser status: Not intentionally manufactured with PVC or DEHP in the syringe components.

Formulation

  • Device type: Two-piece syringe with fixed hypodermic needle.
  • Nominal capacity: 1.0 mL maximum dosage.
  • Graduation scale: 0.25, 0.5, 0.75 and 1.0 mL barrel markings, with 0.25 mL incremental markings to support variable dosing.
  • Needle specification: 23G (0.5 mm) x 25 mm (1 inch) pre-attached, fixed needle.
  • Dead space: Designed as low-dead-space syringe, typically < 35 microlitres residual volume to reduce vaccine wastage.
  • Configuration: Fixed (non-removable) needle and two-piece syringe barrel/plunger assembly, sterile and single-use.
  • Intended use category: General-purpose aspiration and injection of fluids, with specific optimisation for vaccine administration.
  • Sterilisation: Sterile, single-use; sterilised by an appropriate validated method (e.g., ethylene oxide) as indicated on the packaging.
  • Latex-free: Natural rubber latex not used in material formulation.
  • Colour coding: Orange plunger rod conforming to ISO colour code for 23G needles.

Packaging

  • Primary packaging: Individual sterile units supplied in medical-grade blister or flow-wrap packaging, maintaining sterility until point of use.
  • Sales pack: Box of 200 BD Flu+ syringes (23G, 0.25–1 mL, 25 mm length, 1", orange).
  • Outer carton: Printed cardboard carton identifying product name, gauge, needle length, dose range, lot number, expiry date, sterilisation method, and storage symbols.
  • Typical case quantity: Multiple boxes per shipping case (exact configuration may vary by region and distributor).
  • Labelling: Marked as sterile, single-use, low-dead-space vaccine syringe with pre-attached needle, and labelled as not made with natural rubber latex.

Usage

  • Use only if you are a trained healthcare professional familiar with vaccine preparation and injection techniques and local immunisation guidelines.
  • Before use, inspect the outer carton and individual sterile pack; do not use the syringe if the packaging is open, damaged, wet or if the expiry date has passed.
  • Open the individual pack aseptically and remove the syringe, taking care not to touch the needle or contaminate the sterile parts.
  • Draw air into the syringe if required by vaccine preparation protocol, then insert the needle into the vaccine vial or ampoule and aspirate the required dose, using the 0.25–1 mL graduation scale for accurate measurement.
  • Tap the barrel gently and expel any visible air bubbles in accordance with institutional procedures, ensuring the final dose volume aligns with the prescribed amount.
  • Prepare the injection site according to local guidelines (e.g., skin cleansing and appropriate selection of injection site and route such as intramuscular or subcutaneous).
  • Insert the needle using the recommended angle and depth for the vaccine and route of administration; stabilise the syringe with the finger flanges and inject the vaccine at a controlled rate by depressing the plunger.
  • After injection, withdraw the needle safely and immediately dispose of the entire syringe–needle unit into a suitable sharps container; do not attempt to recap, bend, break or otherwise manipulate the needle.
  • Do not attempt to detach the needle from the syringe; the needle is fixed and the device is intended for single use only.
  • Follow national immunisation guidelines, vaccine Summary of Product Characteristics (SmPC) and institutional policies for vaccine handling, dosing and administration, as well as sharps safety and disposal.

Contraindications

  • Do not use if the sterile packaging is damaged, opened or compromised, or if the product is past its labelled expiry date.
  • Do not reuse, reprocess or resterilise; the syringe and needle are intended strictly for single use.
  • Do not use if the needle is visibly bent, blunted, corroded or otherwise damaged, or if the syringe barrel or plunger appears cracked or deformed.
  • Do not use for infusion or continuous administration; the device is designed for single-dose injection only.
  • Do not attempt to use the device for high-pressure injection beyond the design limits (e.g., power injection), as this may cause leaks or failure.
  • Avoid use in patients with known hypersensitivity to any component materials if such hypersensitivity is clinically relevant, although the syringe is not made with natural rubber latex.
  • Do not use for intrathecal, intra-ocular or other specialised injection routes unless clearly indicated and consistent with local clinical guidance and product labelling.

Adverse Effects

  • Local injection site reactions such as pain, redness, itching, bruising or swelling, typically related to the vaccine or medication and the injection procedure rather than the syringe itself.
  • Bleeding or haematoma formation at the injection site, especially in patients with coagulation disorders or on anticoagulant therapy.
  • Potential infection or abscess at the injection site if aseptic technique is not properly followed.
  • Rare risk of nerve or tissue injury if the injection is placed incorrectly or into inappropriate anatomical locations.
  • Risk of air embolism if air is not adequately expelled prior to intravascular injection; this is mitigated by correct priming and technique.
  • Occupational exposure risk to healthcare workers (e.g., needlestick injuries and exposure to bloodborne pathogens) if sharps handling and disposal procedures are not followed.
  • Systemic adverse effects associated with the administered vaccine or medication (e.g., allergic reactions, anaphylaxis), which are related to the drug product rather than the syringe.

Storage Conditions

  • Store in a clean, dry environment at controlled room temperature, within the range specified on the packaging.
  • Keep away from direct sunlight and excessive heat sources, which could affect packaging integrity and device materials.
  • Avoid exposure to excessive moisture or high humidity that could compromise the sterile packaging.
  • Store the syringes in their original cartons until use to protect them from dust, physical damage and contamination.
  • Do not freeze or expose to extreme temperatures that fall outside the manufacturer’s recommended storage range.
  • Do not use the product after the expiry date indicated on the primary pack and outer carton.

Duration

Single-use device used for one vaccine or medication preparation and injection episode only; it is not intended for prolonged or repeated use. Overall treatment or immunisation schedule duration is determined by the specific vaccine or therapy, not by the syringe.

Onset

Not applicable to the device itself; onset of effect is determined by the specific vaccine or medicinal product, dose and route of administration rather than by the syringe.

Browse more Medical device \u2013 syringe with fixed needle

Top Treatments

Top Cities in the UK